APA (7th ed.) Citation

AG, K., M, S., JS, S., N, M., S, N., U, E., . . . Y, W. (2026). Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy. Therapeutic advances in medical oncology, 18, 17588359261417635. https://doi.org/10.1177/17588359261417635

Chicago Style (17th ed.) Citation

AG, Kuang, et al. "Gastrointestinal Adverse Events Following Brentuximab Vedotin and Polatuzumab Vedotin Therapy." Therapeutic Advances in Medical Oncology 18 (2026): 17588359261417635. https://doi.org/10.1177/17588359261417635.

MLA (9th ed.) Citation

AG, Kuang, et al. "Gastrointestinal Adverse Events Following Brentuximab Vedotin and Polatuzumab Vedotin Therapy." Therapeutic Advances in Medical Oncology, vol. 18, 2026, p. 17588359261417635, https://doi.org/10.1177/17588359261417635.